BusinessHealthWorld

Western Blotting Market To Transform Beyond Conventional Means At A CAGR Of 5.4% From 2021

Western Blotting Market

The Western Blotting Market Share is expected to be worth US$ 725 Million at a CAGR of 5.4% between 2021. The healthcare vertical’s success is attributed to the usage of the best technologies, right from diagnoses to patient care. As such, effective patient communication would be the running trend going forward. This would be the DNA of the healthcare vertical between 2021.

The rising incidence of HIV, growing applications of western blotting technique in the field of proteomics and the growing expenditure on research and development by various pharmaceutical and biotechnology companies are some of the major factors stimulating the growth of the global western blotting market during the forecast period, 2017-2021.

These are some of the findings of the latest comprehensive report which has been released by Persistence Market Research titled as ‘Western Blotting Market: Global Industry Analysis and Forecast 2017-2021’. This report explores the market dynamics affecting the expansion of the global western blotting market in the form of drivers, restraints, opportunities and trends, which are comprehensively studied in this latest report.

How About Looking Through The Sample Of Western Blotting Market Report? https://www.persistencemarketresearch.co/samples/3044

Company Profiles :

  • Thermo Fisher Scientific, Inc.
  • GE Healthcare.
  • Hoffmann-La Roche Ltd.
  • Danaher Corporation (Lumigen, Inc.)
  • EMD Millipore Corporation.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc., LI-COR, Inc.
  • Bio-Techne Corporation (ProteinSimple Inc.)
  • Advansta, Inc.

How About Step-By-Step Insights To Western Blotting Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/3044

As per the forecast, the global western blotting market was valued at US$ 576.4 Mn in 2017 end and is slated to reach a valuation of US$ 725 Mn in 2021 end, reflecting a CAGR of 5.9% during the period of forecast 2017-2021.

Global Western Blotting Market: Market Dynamics

According to the data provided by UNAIDS, there were approximately 36.7 million people across the global living with HIV/AIDS. Western blot testing method is preferred in detection on HIV as it is greatly accurate in finding HIV antibodies in the blood of patients as compared with other testing techniques like ELISA. The diagnosis of HIV is dependent on the detection of the HIV antibody in blood, by the incorporation of HIV antigens. This kind of antigen-antibody assay is helpful in window period of HIV.

Hence, western blotting testing technique is preferred in the detection of anti-HIV antibody in blood serum sample. In addition, there is an increasing amount of investments in R&D sector in the western blotting market for system automation, antibodies, regent kits and buffers.

Such kind of investments are likely to boost the growth of the global western blotting market. However, the emergence of alternative techniques like the alpha technique, which is much simpler than the western blotting technique may restrain the growth of the global western blotting market.

Want To Keep A Tab On The Latest Findings In The Western Blotting Market? Purchase Our Western Blotting Market Report Now! https://www.persistencemarketresearch.com/checkout/3044

Global Western Blotting Market: Segmentation and Forecast

The global western blotting market is segmented on the basis of product, end-use, application and region.

On the basis of product, the reagent kits dominated the market. The reagent kits segment was valued at US$ 350.5 Mn in 2017 end. The transfer membranes segment was valued at US$ 62.3 Mn in 2017 end. Innovative reagents are being used for clear visibility and imaging and to reduce the duration of test process are some of the key factors boosting the growth of the reagents kits segment in the western blotting market.

On the basis of application, the scientific research segment was valued at US$ 215.7 Mn in 2017 end. The food and beverage segment was valued at US$ 60.9 Mn in 2017 end. Scientific research segment is projected to reach US$ 277.0 Mn by 2021, creating a total incremental opportunity of US$ 88.3 Mn over the forecast period.

On the basis of end-use, the diagnostic laboratories segment was valued at US$ 145.7 Mn in 2017 end. Need for continuous monitoring of patients suffering from HIV is expected to fuel demand for western blotting tests over the forecast period.

On the basis of region, the Asia Pacific western blotting market was valued at US$ 129.2 Mn in 2017 end. There is a high potential for the growth of western blotting market in the region of Asia Pacific.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Back to top button